Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies
Current Opinion in Infectious Diseases, 07/03/08
Marr KA - Clinicians should consider using new mold-active azole drugs for prophylaxis instead of fluconazole in allogeneic hematopoietic stem cell transplant recipients that have high risks due to prolonged neutropenia and severe graft vs. host disease. More investigations are needed to support other preventive strategies that utilize diagnostic tests and aerosolized delivery of amphotericin B formulations.
| Previous Article | Next Article |
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Empiric Antimicrobial Therapy for Pediatric Skin and Soft-Tissue Infections in the Era of Methicillin-Resistant Staphylococcus aureus
Pediatrics, 05/27/09
Caspofungin for the treatment of candidaemia in patients with haematological malignancies
Clinical Microbiology and Infection, 06/29/09
Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998-2004
BMC Pediatrics, 06/25/09
Article Search
Sponsor


See Latest Articles


